Top Abstract Purchase Related
Home
>
Node
>
Subnode

Insulin immunology: humoral and cellular aspects in mono-component insulin treated patients

Devlin, J.G.; Maguire, O.; Parameswaran, V.; Blake, P.J.

Postgraduate Medical Journal 55(Suppl 2): 14-18

1979

ISSN/ISBN: 0032-5473
PMID: 482193
Document Number: 142166
A study on humoral and cellular immune response to monocomponent (MC) insulin is reported. Humoral insulin antibody did not reach detectable levels in 80% of patients studied. Two out of six patients in whom a detectable antibody response was found had bovine species specific antibody suggesting some contamination of the insulin preparation used. No evidence for lymphocyte transformation with MC insulin was observed in the patients treated. B component resulted in transformation in patients treated with non-MC insulins. Zinc acted as a stimulant to lymphocyte transformation in the control group. The significance of the observations is discussed.

Document emailed within 1 workday
Secure & encrypted payments

Devlin, J.G.; Parameswaran, V. 1975: Immunologic response to mono-component insulin in newly diagnosed diabetic patients Irish Medical Journal 68(12): 301-305
Hellman, B.; Gylfe, E.; Grapengiesser, E.; Dansk, H.én.; Salehi, A. 2007: Insulin oscillations--clinically important rhythm. Antidiabetics should increase the pulsative component of the insulin release Lakartidningen 104(32-33): 2236-2239
Chang, T.C.; Wang, L.M.; Cheng, C.Y.; Kuo, H.F.; Liu, P.C.; Ho, L.T. 1990: The action of gliclazide on insulin secretion and insulin sensitivity in non-obese non-insulin dependent diabetic patients Zhonghua Yi Xue Za Zhi 46(2): 79-85
Hildebrandt, P. 1991: Subcutaneous absorption of insulin in insulin-dependent diabetic patients. Influence of species, physico-chemical properties of insulin and physiological factors Danish Medical Bulletin 38(4): 337-346
Hamaguchi, T.; Sadahiro, K.; Satoh, T. 2015: Current concept of insulin therapy intensification, and the role of human regular insulin and rapid-acting insulin analogs in insulin treatment Nihon Rinsho. Japanese Journal of Clinical Medicine 73(3): 447-452
2000: First insulin sensitizer approved in Germany. Insulin resistance in type 2 diabetes can be treated MMW Fortschritte der Medizin 142(36): 50
Wójcikowski, C. 1976: Determination of free and total insulin in insulin-treated diabetics Endokrynologia Polska 27(1): 63-70
Molnar, G.D.; Taylor, W.F.; Langworthy, A.L. 1972: Plasma immunoreactive insulin patterns in insulin-treated diabetics. Studies during continuous blood glucose monitoring Mayo Clinic Proceedings 47(10): 709-719
Korányi, L.; Tamás, G.; Gerö, L.; Halmos, T.; Baranyai, E.; Büki, B. 1981: Glucagon antibodies in the blood of insulin-treated diabetics (effect of monospecific and monocomponent insulin therapy on antibody level) Orvosi Hetilap 122(23): 1371-1374
Ditsov, S.; Penchev, I.; Andreev, D.; Sirakov, L.; Turkolev, N. 1972: Insulin antibodies in untreated and insulin-treated diabetics Vutreshni Bolesti 11(3): 95-99
Csaba, G.; Török, O.; Kovács, P. 1984: Hormonal imprinting in cell culture I. Impact of a single exposure to insulin on cellular insulin binding capacity in permanent cell lines Acta Physiologica Hungarica 64(1): 57-63
Larkins, R.G.; Zajac, J.; Saunders, R.; Read, A.; Hopper, J.L. 1986: Comparative double-blind trial of the effectiveness and antigenicity of semisynthetic human insulin and purified porcine insulin in newly treated diabetic subjects Australian and New Zealand Journal of Medicine 16(2): 206-210
Szmigiel, Z. 1973: Some aspects of the disturbances of humoral and cellular immunological barrier in leukemia patients Przeglad Lekarski 30(6): 514-517
Klöppel, G.; Freytag, G.; Graesslin, D. 1973: Preparation of monomer insulin components and insulin-like contaminants from crystalline insulin by isoelectric focusing technique Acta Endocrinologica. Supplementum 173: 58
De Meijer, P.H.; Lutterman, J.A. 1990: Subcutaneous injection with an insulin pen. Insulin absorption and plasma concentrations of glucose and free insulin Netherlands Journal of Medicine 36(1-2): 4-12
Fernández Landó, L.; Massari, F.; Oviedo, A.; Jiang, H. 2012: Starting an insulin regimen with insulin lispro mix 25 versus glargine insulin for type 2 diabetes Medicina 72(3): 235-242
Beck-Nielsen, H.; Henriksen, J.E.; Alford, F.; Hother-Nielson, O. 1996: In vivo glucose metabolism, insulin secretion and, insulin action in Europids with non-insulin-dependent diabetes mellitus (NIDDM) and their first-degree relatives Diabetic Medicine: a Journal of the British Diabetic Association 13(9 Suppl 6: S78-S84
Lepore, G.; Dodesini, A.R.; Nosari, I.; Trevisan, R. 2004: Effect of continuous subcutaneous insulin infusion vs multiple daily insulin injection with glargine as basal insulin: an open parallel long-term study Diabetes Nutrition and Metabolism 17(2): 84-89
De Meyts, P. 1994: Insulin receptors and mechanism of action of insulin and of insulin-like growth factors Bulletin et Memoires de l'Academie Royale de Medecine de Belgique 149(3-4): 181-190; Discussion: 190-194
Perelygina, A.A.; Smirnova, O.M.; Lobanova, A.M.; Gorelysheva, V.A. 1988: Use of human insulin preparations in the treatment of patients with insulin-dependent diabetes mellitus Problemy Endokrinologii 34(1): 3-5